Day One Biopharmaceuticals, Inc. (DAWN)

8.43 +0.01 (+0.12%) USD  |  NASDAQ  |  Dec 12, 10:27
More

Day One Biopharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for DAWN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Mersana Therapeutics, Inc. Upgrade
Iovance Biotherapeutics, Inc. Upgrade
Lantheus Holdings, Inc. Upgrade
iRhythm Technologies, Inc. Upgrade
Perspective Therapeutics, Inc. Upgrade